Process View
Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "vascular wound healing"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | ||
| NRP1 | neuropilin 1 | 1.000 | ||
| VEGFA | vascular endothelial growth factor A | 1.000 | Human | |
| PLAU | plasminogen activator, urokinase | 1.000 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 1.000 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.999 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.999 | Human | |
| PGF | placental growth factor | 0.992 | Human | |
| COL4A1 | collagen, type IV, alpha 1 | 0.985 | ||
| PLAT | plasminogen activator, tissue | 0.964 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.932 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.925 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.822 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.759 | ||
| PLAUR | plasminogen activator, urokinase receptor | 0.718 | ||
| PDGFC | platelet derived growth factor C | 0.703 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.593 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.561 | ||
| STC1 | stanniocalcin 1 | 0.499 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.476 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.470 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.331 | ||
| ENG | endoglin | 0.289 | ||
| LAMA5 | laminin, alpha 5 | 0.288 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.268 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.266 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.219 | ||
| THBS1 | thrombospondin 1 | 0.177 | ||
| LDLR | low density lipoprotein receptor | 0.171 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.145 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.123 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.112 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.091 | ||
| PXDN | peroxidasin homolog (Drosophila) | 0.086 | ||
| VEGFC | vascular endothelial growth factor C | 0.081 | Human | |
| COL16A1 | collagen, type XVI, alpha 1 | 0.077 | ||
| ANGPTL4 | angiopoietin-like 4 | 0.075 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.074 | ||
| PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.071 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.071 | ||
| AES | amino-terminal enhancer of split | 0.065 | ||
| ANGPT2 | angiopoietin 2 | 0.063 | ||
| ORM1 | orosomucoid 1 | 0.056 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.055 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.050 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.050 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.050 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.048 | ||
| ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.047 | ||
| SPHK1 | sphingosine kinase 1 | 0.046 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.042 | ||
| CSPG4 | chondroitin sulfate proteoglycan 4 | 0.041 | ||
| SLC2A3 | solute carrier family 2 (facilitated glucose transporter), member 3 | 0.041 | ||
| FOSL2 | FOS-like antigen 2 | 0.039 | ||
| SLC6A8 | solute carrier family 6 (neurotransmitter transporter, creatine), member 8 | 0.038 | ||
| NRP2 | neuropilin 2 | 0.038 | ||
| STC2 | stanniocalcin 2 | 0.036 | ||
| JAG1 | jagged 1 | 0.036 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.035 | ||
| TNFRSF10B | tumor necrosis factor receptor superfamily, member 10b | 0.035 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.035 | ||
| PALM | paralemmin | 0.033 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.032 | ||
| MDFI | MyoD family inhibitor | 0.031 | ||
| NNMT | nicotinamide N-methyltransferase | 0.029 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.029 | ||
| FST | follistatin | 0.028 | ||
| IER3 | immediate early response 3 | 0.027 | ||
| LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.026 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.025 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.024 | ||
| VWF | von Willebrand factor | 0.024 | ||
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.024 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.024 | ||
| INHBA | inhibin, beta A | 0.023 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.022 | ||
| TNC | tenascin C | 0.022 | ||
| NFIL3 | nuclear factor, interleukin 3 regulated | 0.022 | ||
| IL8 | interleukin 8 | 0.021 | ||
| NOTCH3 | notch 3 | 0.021 | ||
| ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.021 | ||
| ERG | v-ets erythroblastosis virus E26 oncogene homolog (avian) | 0.020 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.019 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.019 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.018 | ||
| BGN | biglycan | 0.018 | ||
| CD248 | CD248 molecule, endosialin | 0.017 | ||
| G0S2 | G0/G1switch 2 | 0.017 | ||
| BMP4 | bone morphogenetic protein 4 | 0.017 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.017 | ||
| NOTCH4 | notch 4 | 0.017 | ||
| PLOD2 | procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 | 0.017 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.017 | ||
| ESAM | endothelial cell adhesion molecule | 0.016 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.016 | ||
| FADS3 | fatty acid desaturase 3 | 0.016 | ||
| PVR | poliovirus receptor | 0.016 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.016 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.015 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.015 | ||
| ADIPOQ | adiponectin, C1Q and collagen domain containing | 0.015 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.015 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.015 | ||
| LOXL2 | lysyl oxidase-like 2 | 0.015 | ||
| GTPBP2 | GTP binding protein 2 | 0.014 | ||
| VAT1 | vesicle amine transport protein 1 homolog (T. californica) | 0.014 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.014 | ||
| TBX2 | T-box 2 | 0.014 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.014 | ||
| FOSL1 | FOS-like antigen 1 | 0.014 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.014 | ||
| FNDC3B | fibronectin type III domain containing 3B | 0.014 | ||
| TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.014 | ||
| LAMB2 | laminin, beta 2 (laminin S) | 0.013 | ||
| EMCN | endomucin | 0.013 | ||
| TNS1 | tensin 1 | 0.013 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.013 | ||
| JAG2 | jagged 2 | 0.013 | ||
| VTN | vitronectin | 0.013 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.013 | ||
| MMRN2 | multimerin 2 | 0.013 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.012 | ||
| SERPINH1 | serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) | 0.012 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.012 | ||
| CALCRL | calcitonin receptor-like | 0.012 | ||
| OSMR | oncostatin M receptor | 0.012 | ||
| PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 | 0.012 | ||
| TGIF1 | TGFB-induced factor homeobox 1 | 0.012 | ||
| PTHLH | parathyroid hormone-like hormone | 0.012 | ||
| NID2 | nidogen 2 (osteonidogen) | 0.012 | ||
| MMRN1 | multimerin 1 | 0.011 | ||
| PCDH17 | protocadherin 17 | 0.011 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.011 | ||
| PDE2A | phosphodiesterase 2A, cGMP-stimulated | 0.011 | ||
| HBEGF | heparin-binding EGF-like growth factor | 0.011 | ||
| HAS2 | hyaluronan synthase 2 | 0.011 | ||
| MCAM | melanoma cell adhesion molecule | 0.011 | ||
| SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.010 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.010 | ||
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.010 | ||
| ULBP2 | UL16 binding protein 2 | 0.010 | ||
| THY1 | Thy-1 cell surface antigen | 0.010 |